ESPR icon

Esperion Therapeutics

122 hedge funds and large institutions have $75.9M invested in Esperion Therapeutics in 2023 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 36 increasing their positions, 31 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.67M
Puts
$335K
Net Calls
Net Calls Change

Top Buyers

1 +$4.64M
2 +$2.4M
3 +$1.8M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$1.61M
5
Marshall Wace
Marshall Wace
United Kingdom
+$1.23M

Top Sellers

1 -$12.8M
2 -$1.84M
3 -$1.58M
4
B
Braidwell
Connecticut
-$1.25M
5
MG
Meditor Group
Bermuda
-$599K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$586K
27
$509K
28
$468K
29
$405K
30
$359K
31
$305K
32
$296K
33
$283K
34
$263K
35
$249K
36
$248K
37
$224K
38
$219K
39
$202K
40
$199K
41
$198K
42
$191K
43
$178K
44
$172K
45
$155K
46
$131K
47
$114K
48
$111K
49
$102K
50
$87.3K